ONCOINVENT is a Norwegian biotechnology company focused on developing radiopharmaceutical products for the treatment of cancer. Its work centers on targeted radionuclide therapies and related clinical development activities.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!